| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.04 | 0.5 |